AMH and thalassemia: Although multivariable regression models, age-stratified analyses, and AMH interaction analyses were employed to adjust for key factors such as age and ovarian reserve, inherent differences in the clinical indications between the thalassemia and non-thalassemia groups—primarily genetic versus DOR/AMA—may still result in residual confounding.